FACE IPF
HEAD ON
and modify disease progression by slowing lung function decline
![thumbnail-image](/mea/lb/sites/default/files/2023-08/media%402x.png)
KOL's Prof. Cottin, Prof. Wuyts, Prof. Maher and Dr. Hoffmann-Vold talking about monitoring for progression
24/05/2022 | Author: Boehringer Ingelheim
KOL's Prof. Cottin, Prof. Wuyts, Prof. Maher and Dr. Hoffmann-Vold talking about monitoring for progression
Document ID: PC-LB-100398